Viropharma

4
Vote

ViroPharma is buying Lev for $442M

Lev Pharma, that focuses on inflammatory diseases is being acquired by ViroPharma for $442 Million. ViroPharma is paying $2.25 per share in cash and 50 cents per share in stock. more...

Discuss | Topic: Mergers and Acquisitions | by Jitendra 142 days ago (fiercebiotech.com)

« previous1 next »